Bnp Paribas »

Sensei Biotherapeutics shares owned by Bnp Paribas

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Bnp Paribas from 13F filings

Historical chart of Bnp Paribas investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Bnp Paribas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Bnp Paribas

Quarter filed Position value Share count Share price at filing
2025-12-31 $59 7 8.43

More positions owned by Bnp Paribas

iShares iBoxx $ High Yield Corporate Bond ETF Fund (HYG)
iShares iBoxx $ Investment Grade Corporate Bond ETF Fund (LQD)
Microsoft Corp Equity (MSFT)
Nvidia Corporation Equity (NVDA)
Apple Equity (AAPL)
Alphabet Inc Cap Stk Cl C Equity (GOOG)
Amazon Equity (AMZN)
Broadcom Equity (AVGO)
Jpmorgan Chase & Co Equity (JPM)
Alphabet Inc Cap Stk Cl A Equity (GOOGL)
Visa Inc Com Cl A Equity (V)
Taiwan Semiconductor Mfg Equity (TSM)
Palo Alto Networks Equity (PANW)
Coca Cola Equity (KO)
Applied Matls Equity (AMAT)

View all positions for Bnp Paribas

Top funds holding Sensei Biotherapeutics

Ikarian Capital
Catalio Capital Management
Renaissance Technologies
Jpmorgan Chase & Co
Bnp Paribas Arbitrage, Snc
Bnp Paribas
SBI Securities

View all funds holding Sensei Biotherapeutics